Atlas Trials

SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.

Clinical trial NCT02798744 · COMPLETED

Trial details

NCT number
NCT02798744
Sponsor
University of Leicester
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2016-12-01
Primary completion
2019-07-30
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.